home All News open_in_new Full Article

Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update

Key Highlights ZUNVEYL Launch Momentum: Completed the first quarter of ZUNVEYL commercialization, achieving approximately $2 million in net product revenues year-to-date. Advancing ALPHA-1062: Completed pre-clinical Bomb Blast study in collaboration with the U.S. Department of Defense and the Seattle Institute of Biomedical and Clinical Research. Strong Balance Sheet: Cash and cash equivalents of $39.4 million […]


today 42 h. ago attach_file Culture

attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Culture
attach_file Culture
attach_file Other
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Society
attach_file Other
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture


ID: 3384421802
Add Watch Country

arrow_drop_down